Stay updated on IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision history now lists version v3.3.2. The previous version v3.2.0 has been removed from the history.
    Difference
    0.1%
    Check dated 2025-11-25T11:16:28.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Removed the government funding notice banner that warned about potential delays and operating status in the page header. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T07:12:54.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Record History shows multiple version updates with changes to Study Status, Recruitment Status, Contacts/Locations, and Outcome Measures.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:17.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    11%
    Check dated 2025-10-06T05:53:43.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-29T03:12:58.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; 'Back to Top' link removed. This is a minor maintenance update with no substantive content changes.
    Difference
    0.6%
    Check dated 2025-09-14T19:50:22.000Z thumbnail image

Stay in the know with updates to IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IO102/IO103 Combo + Pembrolizumab in Melanoma Clinical Trial page.